Related Experiment Video
Updated: Apr 26, 2026
08:47
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
12.6K
Intracellular lipid accumulation and shift during diabetes progression
Peter Wolf1, Yvonne Winhofer, Christian-Heinz Anderwald
1Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Wiener Medizinische Wochenschrift (1946)
|July 23, 2014
Summary
Ectopic lipid accumulation is a key predictor of type 2 diabetes mellitus (T2DM) and insulin resistance. This review explores how intracellular fat impacts T2DM development and treatment, highlighting future research directions.
Area of Science:
- Metabolic diseases
- Endocrinology
- Hepatology
Background:
- Type 2 Diabetes Mellitus (T2DM) and nonalcoholic fatty liver disease are global health issues.
- Ectopic lipid accumulation is strongly linked to insulin resistance and T2DM pathogenesis.
- Understanding the role of intracellular fat is crucial for metabolic disease research.
Purpose of the Study:
- To review the impact of intracellular lipid deposition on T2DM and insulin resistance.
- To examine changes in ectopic fat during diabetes progression and therapy.
- To identify future research directions concerning ectopic lipids in T2DM.
Main Methods:
- Literature review of recent studies.
- Analysis of ectopic fat accumulation in T2DM progression.
- Synthesis of current knowledge on insulin resistance and lipid metabolism.
Main Results:
- Ectopic lipid accumulation is a significant predictor of T2DM.
- Changes in fat deposition occur during disease progression and treatment.
- The precise mechanisms linking ectopic lipids to insulin resistance require further investigation.
Conclusions:
- Ectopic fat plays a critical role in the development of insulin resistance and T2DM.
- Further research is needed to elucidate the complex interplay between lipids and metabolic dysfunction.
- Targeting ectopic lipid accumulation may offer therapeutic strategies for T2DM.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
19
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
19
01:26Type I Diabetes II: Pathophysiology
57
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
57
01:27Diabetic Retinopathy
48
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
48
01:19Type I Diabetes III: Clinical Manifestations
19
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
19
01:38Inflammation
46.2K
Overview
46.2K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K